Showing results (91-100 of 190) with videos related to
Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignanciesBirgit Geoerger, Bruce Morland, Irene Jiménez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomasStéphanie Puget, Jacques Grill, Alexander Valent, et al.British Journal of Haematology|June 26, 2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinibNina Prokoph, Jamie D Matthews, Ricky M Trigg, et al.Cell Reports|October 23, 2021
Synaptogenic activity of the axon guidance molecule Robo2 underlies hippocampal circuit functionHeike Blockus, Sebi V Rolotti, Miklos Szoboszlay, et al.European Journal of Cancer (Oxford, England : 1990)|May 13, 2023
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trialBirgit Geoerger, Lynley V Marshall, Karsten Nysom, et al.Nature Medicine|May 29, 2023
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutationBirgit Geoerger, Manuel Schiff, Virginie Penard-Lacronique, et al.The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.European Journal of Cancer (Oxford, England : 1990)|April 23, 2021
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer ConsortiumClaudia Pasqualini, Jonathan Rubino, Caroline Brard, et al.Journal of Pediatric Hematology/Oncology|August 30, 2014
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experienceFrancisco Bautista, Angela Di Giannatale, Nathalie Dias-Gastellier, et al.Neuro-Oncology Advances|August 19, 2021
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastomaVictor Pereira, Jacob Torrejon, Dulanjalee Kariyawasam, et al.Pageof 19